Therapeutic significance of ectophosphatase inhibitors in reversal of multi-drug resistance [6]

Medical Hypotheses

Volumn 66, Issue 5, 2006, Pages 1041-1042

  Kannan, Subburaj ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ECTO 5' NUCLEOTIDASE; ECTOPHOSPHATASE INHIBITOR; ENZYME INHIBITOR; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

EFFUSION; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROLYSIS; LETTER; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEADY STATE; TREATMENT OUTCOME; TUMOR CELL;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; P-GLYCOPROTEIN; PHOSPHORIC MONOESTER HYDROLASES; PROGNOSIS;

EID: 32144449462     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.12.017     Document Type: Letter

References (6)

1. Gros P, Hanna M, The p-glycoprotein family and multidrug resistance: an overview. In: Konigs WN, Kaback HR, Lolkema JS, editors. Handbook of biological physics, vol. 7; 1996. p. 137-63.
2. C. Thomas, A. Rajagopal, B. Windsor, R. Dudler, A. Lloyd, and S.J. Roux A role for ectophosphatase in xenobiotic resistance Plant Cell 12 4 2000 519 533
3. S. Karasaki, and T. Okigaki Surface membrane nucleoside triphosphatase activity and tumorigenicity of cultured liver epithelial cells Cancer Res 36 1976 4491 4499
4. 2+ transport via gated channel Theor Biol Med Model 1 1 2004 3
5. P. Ujhazy, M. Klobusicka, O. Babusikova, P. Strausbauch, E. Mihich, and M.J. Ehrke Ecto-5′-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin Int J Cancer 59 1994 83 93
6. Int J Cancer 68 1996 493 500